Glucagon and insulin are commonly believed to have counteracting effects on blood glucose levels. However, recent studies have demonstrated that glucagon has a physiologic role to activate β cells and enhance insulin secretion. To date, the actions of glucagon have been studied mostly in fasting or hypoglycemic states, yet it is clear that mixed-nutrient meals elicit secretion of both glucagon and insulin, suggesting that glucagon also contributes to glucose regulation in the postprandial state. We hypothesized that the elevated glycemia seen in the fed state would allow glucagon to stimulate insulin secretion and reduce blood glucose. In fact, exogenous glucagon given under fed conditions did robustly stimulate insulin secretion and lower glycemia. Exogenous glucagon given to fed Gcgr:Glp1rβcell–/– mice failed to stimulate insulin secretion or reduce glycemia, demonstrating the importance of an insulinotropic glucagon effect. The action of endogenous glucagon to reduce glycemia in the fed state was tested with administration of alanine, a potent glucagon secretagogue. Alanine raised blood glucose in fasted WT mice or fed Gcgr:Glp1rβcell–/– mice, conditions where glucagon is unable to stimulate β cell activity. However, alanine given to fed WT mice produced a decrease in glycemia, along with elevated insulin and glucagon levels. Overall, our data support a model in which glucagon serves as an insulinotropic hormone in the fed state and complements rather than opposes insulin action to maintain euglycemia.
Megan E. Capozzi, Jacob B. Wait, Jepchumba Koech, Andrew N. Gordon, Reilly W. Coch, Berit Svendsen, Brian Finan, David A. D’Alessio, Jonathan E. Campbell
Title and authors | Publication | Year |
---|---|---|
Glucagon-receptor signaling regulates weight loss via central KLB receptor complexes
Shelly R Nason, Jessica P. Antipenko, Natalie Presedo, Stephen E. Cunningham, Tanya H Pierre, Teayoun Kim, Jodi R Paul, Cassie L Holleman, Martin Young, Karen L. Gamble, Brian Finan, Richard DiMarchi, Chad S Hunter, Alexei Kharitonenkov, Kirk M Habegger |
JCI Insight | 2021 |
α-cell Gq signaling is critical for maintaining euglycemia
Liu Liu, Diptadip Dattaroy, Katherine Simpson, Luiz F. Barella, Yinghong Cui, Yan Xiong, Jian Jin, Gabriele König, Evi Kostenis, Jefferey C Roman, Klaus H. Kaestner, Nicolai Doliba, Jürgen Wess |
JCI Insight | 2021 |
SCO-267, a GPR40 Full Agonist, Stimulates Islet and Gut Hormone Secretion and Improves Glycemic Control in Humans
H Nishizaki, O Matsuoka, T Kagawa, A Kobayashi, M Watanabe, Y Moritoh |
Diabetes | 2021 |
Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes
A Kim, JG Knudsen, JC Madara, A Benrick, T Hill, L Abdul-Kadir, JA Kellard, L Mellander, C Miranda, H Lin, T James, K Suba, AF Spigelman, Y Wu, PE Macdonald, IW Asterholm, T Magnussen, M Christensen, T Visboll, V Salem, FK Knop, P Rorsman, BB Lowell, LJ Briant |
eLife | 2021 |
New Aspects of Diabetes Research and Therapeutic Development
LS Satin, SA Soleimanpour, EM Walker, L Isom |
Pharmacological reviews | 2021 |
Mechanisms controlling pancreatic islet cell function in insulin secretion
JE Campbell, CB Newgard |
Nature Reviews Molecular Cell Biology | 2021 |
The Insulin Centennial—100 years of milestones in biochemistry
AD Attie, QQ Tang, KE Bornfeldt |
The Journal of biological chemistry | 2021 |
The Insulin Centennial—100 years of milestones in biochemistry
AD Attie, QQ Tang, KE Bornfeldt |
Journal of lipid research | 2021 |
β-Cell Knockout of SENP1 Reduces Responses to Incretins and Worsens Oral Glucose Tolerance in High-Fat Diet–Fed Mice
H Lin, N Smith, AF Spigelman, K Suzuki, M Ferdaoussi, TA Alghamdi, SL Lewandowski, Y Jin, A Bautista, YW Wang, JE Fox, MJ Merrins, J Buteau, PE MacDonald |
Diabetes | 2021 |
Preproglucagon Products and Their Respective Roles Regulating Insulin Secretion
M Bethea, N Bozadjieva-Kramer, DA Sandoval |
Endocrinology | 2021 |
Glucagon Potentiates Insulin Secretion Via β-Cell GCGR at Physiological Concentrations of Glucose
Y Zhang, C Han, W Zhu, G Yang, X Peng, S Mehta, J Zhang, L Chen, Y Liu |
Cells | 2021 |
Neprilysin Inhibition Increases Glucagon Levels in Humans and Mice With Potential Effects on Amino Acid Metabolism
SA Kjeldsen, LH Hansen, N Esser, S Mongovin, M Winther-Sørensen, KD Galsgaard, JE Hunt, H Kissow, FR Ceutz, D Terzic, PD Mark, P Plomgaard, JP Goetze, GH Goossens, EE Blaak, C F, MM Rosenkilde, S Zraika, JJ Holst, NJ Albrechtsen |
Journal of the Endocrine Society | 2021 |
In Vivo Metabolic Roles of G Proteins of the Gi Family Studied With Novel Mouse Models
J Wess |
Endocrinology | 2021 |
GIP mediates the incretin effect and glucose tolerance by dual actions on α cells and β cells
K El, SM Gray, ME Capozzi, ER Knuth, E Jin, B Svendsen, A Clifford, JL Brown, SE Encisco, BM Chazotte, KW Sloop, DJ Nunez, MJ Merrins, DA DAlessio, JE Campbell |
Science Advances | 2021 |
Evidence for the existence and potential roles of intra-islet glucagon-like peptide-1
SA Campbell, J Johnson, PE Light |
Islets | 2021 |
Non‐peptide agonists and positive allosteric modulators of glucagon‐like peptide‐1 receptors: Alternative approaches for treatment of Type 2 diabetes
F Malik, Z Li |
British Journal of Pharmacology | 2021 |
Chemogenetic approaches to identify metabolically important GPCR signaling pathways: therapeutic implications
Meister J, Wang L, Pydi SP, Wess J |
Journal of Neurochemistry | 2021 |